Statins Too Often Not Taken as Directed To Prevent a Second Heart Attack

Use of statins to prevent the recurrence of a heart attack after the first such incidence is a generally accepted practice guideline, but its effectiveness is muted because of nonadherence, according to a study in JAMA Cardiology. Researchers with the Icahn School of Medicine at Mt. Sinai looked at data on nearly 30,000 Medicare patients who had a prescription for either Lipitor or Crestor between 2007 through 2012. The patients, ages 66 to 75, had been hospitalized for a heart attack.

Most of the patients (58.9%) stuck with the regimen for six months. But two years out, only 41.6% of patients took the medications as directed, and many patients were taking lower doses than they should have been taking. Meanwhile, about 1 in 5 had stopped taking the drugs entirely. Not taking the statins as directed means greater risk of another heart attack, unstable angina, and stroke.

The study concludes: “Many patients filling high-intensity statins following a myocardial infarction do not continue taking this medication with high adherence for two years post-discharge. Interventions are needed to increase high-intensity statin use and adherence after myocardial infarction.”

Source: JAMA Cardiology

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at